All Posts: clinical trials
-
New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients
A new study conducted by an international team of researchers, including clinical investigators at Georgetown Lombardi and John Theurer Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.
Category: News Release
-
Ruesch Symposium Participants Encourage Patients to Consider Clinical Trials
Held by the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center, the Ruesch Symposium brings together researchers, clinicians, patients, caregivers, policymakers and advocates for networking and discussion on the latest developments in GI cancer research and treatment.
Category: GUMC Stories
-
The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology
Category: News Release
-
Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy
Category: News Release
-
Glynda’s Story: A Chance to Advance Treatment for Aggressive Cancer
Category: GUMC Stories
-
FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research
Category: GUMC Stories
-
Clinical Research Staff Rise to the Challenges Posed by Pandemic
(July 31, 2020) — Running clinical research can be complicated under normal circumstances but it’s especially arduous during a pandemic. Despite the difficulties, the clinical research teams at Georgetown have worked tirelessly, remotely and on campus, to continue supporting researchers and study participants. “Our team as a whole really stepped up to do this, and […]
Category: GUMC Stories
-
First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight
Category: GUMC Stories
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]
Category: News Release
-
Pressure to Endorse Use of Unproven Drugs for COVID-19 Threatens Public Confidence
WASHINGTON (April 16, 2020) — The widespread use of experimental treatments for COVID-19, including the antimalarial drugs chloroquine and hydroxychloroquine, represents “ill-advised and uncontrolled human experimentation with unproven treatments,” say two former FDA chief scientists. Furthermore, political pressure or advocacy for specific experimental treatments, such as that surrounding the issuance of an Emergency Use Authorization […]
Category: News Release